Med-Con Technologies News
Med-Con Technologies is supporting global pharmaceutical and CRO companies to reach optimal levels of medication adherence monitoring in clinical trials.
In multi-country/multi-language clinical trials, Med-Con technologies' adherence solution - Med-Con Mobile Smart Label - is assisting patients to more effectively self-manage their medication away from clinical site. In addition, it enhances clinical oversight and provides patient adherence data in real-time.
Med-Con Technologies QMS/GxP Audit Validation.
In a recent audit by Bayer AG, Med-Con Technologies successfully completed an extensive review to validate its company QMS processes and GxP procedures. This was our fourth audit and we have demonstrated solid procedures for important components as: change and risk management, and SDLC. Med-Con Technologies also successfully completed an audit by Thermo Fisher Scientific for its Quality Management Systems and GCP processes.
Med-Con Technologies Signed Contract with Thermo Fisher.
Med-Con Technologies and Thermo Fisher have signed a Master Services Agreement, and Thermo Fisher will add Med-Con Mobile Smart Label and Med-Con Central Software to its portfolio of digital adherence solutions.